☆ 4.5 Article

Real-world experience and long-term evaluation of tofacitinib in refractory alopecia areata: A prospective, open-label, single-center study in Asian Arab population

DERMATOLOGIC THERAPY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Dermatology

Combination tofacitinib and oral minoxidil treatment for severe alopecia areata

Carlos G. Wambier et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

添加到收藏夹

Article Dermatology

Treatment of alopecia areata in pre-adolescent children with oral tofacitinib: A retrospective study

Rebekka Jerjen et al.

Summary: Oral tofacitinib shows promise as a systemic therapy for pediatric patients with alopecia areata, leading to significant improvement in Severity of Alopecia Tool (SALT) scores. The average improvement in SALT score after treatment was 67.7%, with mild adverse events reported.

PEDIATRIC DERMATOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Enhancing intradermal delivery of tofacitinib citrate: Comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays

Alvaro Carcamo-Martinez et al.

Summary: Autoimmune-mediated inflammatory skin diseases such as psoriasis, alopecia areata, and vitiligo can significantly impact patients' quality of life. Treatment with systemic steroids is common but may not always be successful. Recent studies have shown promising results with oral Janus Kinase (JAK) inhibitors, although they come with frequent side effects.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

添加到收藏夹

Article Dermatology

Experience with oral tofacitinib in severe alopecia areata with different clinical responses

Didem Dincer Rota et al.

Summary: Alopecia areata and its generalized form, universalis, are common causes of noncicatricial alopecia. Tofacitinib has shown more promising results in treating AA patients compared to AU patients, with relapse observed in some cases after discontinuation of treatment. Early initiation of therapy may lead to more successful outcomes, and it is important to inform patients about the possibility of relapse to manage expectations.

JOURNAL OF COSMETIC DERMATOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata

Zhenpeng Dai et al.

Summary: The study demonstrates that in the C3H/HeJ mouse model, JAK1-selective and JAK3-selective inhibitors can effectively induce hair regrowth and reduce AA-related inflammation, while JAK2-selective inhibitors show less efficacy.

JCI INSIGHT (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance

Akudo Nwaogu et al.

Summary: Tofacitinib, an oral Janus kinase molecule, has demonstrated efficacy in treating rheumatoid arthritis and ulcerative colitis. It has shown superiority in ulcerative colitis treatment and is recommended as an effective option for adult patients unable to tolerate traditional or biological therapies.

FRONTLINE GASTROENTEROLOGY (2021)

添加到收藏夹

Article Dermatology

Effectiveness of Oral Tofacitinib Dose Tapering in a Case of Alopecia Areata Universalis

Mariana Esteves et al.

Summary: The case study presented a successful treatment of a 51-year-old female patient with refractory alopecia universalis using oral tofacitinib, with no recurrence observed after 17 months of therapy. Current therapies for alopecia areata are not reliably effective, but Janus kinase inhibitors are emerging as a promising novel treatment option supported by increasing evidence of their effectiveness.

SKIN APPENDAGE DISORDERS (2021)

添加到收藏夹

Review Dermatology

Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta-analysis

L. Guo et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases

Rebekka Christmann et al.

PHARMACEUTICS (2020)

添加到收藏夹

Review Dermatology

JAK inhibitors for alopecia areata: a systematic review and meta-analysis

K. Phan et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

添加到收藏夹

Letter Medicine, General & Internal

JAK inhibitors and alopecia areata

Amos Gilhar et al.

LANCET (2019)

添加到收藏夹

Article Dermatology

Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study

Nawaf Almutairi et al.

DERMATOLOGY (2019)

添加到收藏夹

Letter Dermatology

Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata

S. C. Gordon et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

添加到收藏夹

Article Dermatology

An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis

A. Jabbari et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)

添加到收藏夹

Review Dermatology

JAK Inhibitors for Treatment of Alopecia Areata

Eddy H. C. Wang et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)

添加到收藏夹

Article Dermatology

Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients

Lucy Y. Liu et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

添加到收藏夹

Article Dermatology

Tofacitinib for the treatment of alopecia areata and variants in adolescents

Brittany G. Craiglow et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

添加到收藏夹

Article Dermatology

Efficacy of tofacitinib in treatment of alopecia universalis in two patients

A. K. Gupta et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)

添加到收藏夹

Article Medicine, Research & Experimental

Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata

Milene Kennedy Crispin et al.

JCI INSIGHT (2016)

添加到收藏夹

Article Medicine, Research & Experimental

Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata

Julian Mackay-Wiggan et al.

JCI INSIGHT (2016)

添加到收藏夹

Letter Dermatology

Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis

Brittany G. Craiglow et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition

Luzhou Xing et al.

NATURE MEDICINE (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.